Vivo Capital VIII LLC 13D and 13G filings for Crinetics Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 5:22 pm Sale | 2021-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Vivo Capital VIII LLC | 0 0.000% | -1,819,600 (Position Closed) | Filing |
| 2021-02-12 4:30 pm Sale | 2020-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Vivo Capital VIII LLC | 1,819,600 5.500% | -425,304 (-18.95%) | Filing |
| 2020-06-11 5:06 pm Sale | 2019-06-10 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Vivo Capital VIII LLC | 2,244,904 6.800% | -853,416 (-27.54%) | Filing |
| 2020-02-13 4:30 pm Sale | 2019-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Vivo Capital VIII LLC | 3,098,320 12.800% | -344,781 (-10.01%) | Filing |